Injective INJ
Rank #97Injective Overview
As of July 19, 2026, Injective (INJ) is trading at $4.86, up 2.37% over the past 24 hours. It ranks #97 by market capitalisation, currently valued at $474.87M, on $55.04M of trading volume in the last 24 hours.
Injective Price Chart Binance
Performance
Market Metrics
Technical Analysis live indicator readings
Moving Averages
Oscillators
Support & Resistance daily pivot levels
All indicators are computed from Binance daily OHLC. This is a summary of current technical readings (overbought/oversold & trend model) — not a price forecast, and not investment advice.
Correlations 90-day, vs majors
Pearson correlation of daily returns over the last 90 days (Binance). +1 moves together, 0 unrelated, −1 moves opposite.
Derivatives Hyperliquid perps
Markets Binance spot
| Pair | Price | 24h Volume |
|---|---|---|
| INJ/USDT | $5.11 | ≈ $3.56M |
| INJ/TRY | 240.9 TRY | ≈ $691.4K |
| INJ/USDC | $5.11 | ≈ $608.6K |
| INJ/TUSD | $26.23 | ≈ $550.2K |
| INJ/BNB | 0.004703 BNB | ≈ $375.0K |
| INJ/ETH | 0.001559 ETH | ≈ $357.0K |
| INJ/BTC | 0.00007877 BTC | ≈ $52.7K |
Live spot pairs on Binance, ranked by USD-equivalent 24-hour volume. For information only.
Price History last 30 days
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| Loading… | |||||
INJ Calculators
Injective Price in Other Currencies
Converted from USD at European Central Bank reference rates (frankfurter.app), updated daily.
Compare with Top Coins
| Coin | Price | 24h | Market Cap |
|---|---|---|---|
| BitcoinBTC | $63,826.50 | +2.96% | $1.28T |
| EthereumETH | $1,769.69 | +2.27% | $213.12B |
| TetherUSDT | $0.9991 | −0.01% | $184.15B |
| BNBBNB | $574.47 | +1.22% | $77.43B |
| USDCUSDC | $0.9998 | −0.01% | $73.32B |
| XRPXRP | $1.10 | +1.76% | $68.97B |
| SolanaSOL | $78.72 | +1.94% | $45.80B |
| InjectiveINJ | $4.86 | +2.37% | $474.87M |
Market Sentiment
Popular Injective searches
Market data is aggregated from public sources (Binance, CoinPaprika, Hyperliquid, Polymarket, alternative.me) for informational purposes only and may be delayed. This is not investment advice.